ACAD
#1341
ACADIA Pharmaceuticals Inc. - Common Stock
29.7 3 USD
+0.01%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.51%
Variación mensual
+13.82%
Variación en los últimos 6 meses
+22.80%
Cambio anual
+13.52%
Cierres anteriores
29.5 8
Open
29.7 3
Mínimo
29.7 3
Máximo
29.7 3
Volumen
98
Financials
- Market Capitalization 5.12 B
- Employee 798
- Founded 1993
- CEO Catherine Owen Adams
- Website www.acadia.com
- Headquarter Delaware, United States
- FIGI BBG000BHG9K0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
11.61
Relación precio/flujo de caja
4.24
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD | ||
| 1272 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.52 USD | -1.16% | -1.24% | -3.43% | +52.05% | 5.67 B USD | ||
| 1374 |  DYN Dyne Therapeutics, Inc. - Common Stock | 26.09 USD | -1.02% | -0.50% | +0.50% | +11.45% | 4.87 B USD | ||
| 1386 |  EWTX Edgewise Therapeutics, Inc. - Common Stock | 44.19 USD | -0.43% | +1.49% | +9.54% | +190.15% | 4.80 B USD |